A New Approach to Assessing Value in Health Care

It’s an important and exciting time in the biotech industry. Spending on prescription drugs has proven to be stable and undeniably low heading into 2018, and today there are approximately 7,000 medicines in development waiting to change the way we treat and cure diseases. Yet as hardworking families and individuals are learning first-hand, health care costs continue to rise so it’s important that we make the necessary adjustments to promote smarter spending across all health care sec